Site Map
Japanese
Business Unit
Pipeline
Social Responsibility
Corporate profile
Our Message
Corporate governance
Operation
Corporate history
List of offices
Business Unit
Ohara Pharmaceutical:Our mission
Orphan drugs (pharmaceuticals for rare medical conditions) business
Generic drugs business
Corporate profile
Our Message
Corporate governance
Operation
Corporate history
List of offices
Entirely from the patients' perspective
Providing dependable pharmaceuticals
for the future of medicine
Ohara Pharmaceutical Co.,Ltd.
News Release
June 20, 2024
Additional Investment in Revital Healthcare (EPZ) Limited
December 19, 2023
Announcement of Recapitalization of Africa Healthcare Network (AHN)-Expansion of healthcare infrastructure through the development of dialysis services in sub-Saharan countries
September 27, 2021
Glucarpidase (Genetical Recombination) “Megludase® ”Marketing Authorization Approval
June 23, 2021
Recombinant Chimeric Monoclonal Antibody "Unituxin®" Marketing Authorization Approval
March 29, 2021
Glucarpidase (Genetical Recombination)"OP-07" Application Filed for Marketing Authorization for Methotrexate Intoxication
View List
Childhood Cancer
Hepato/Biliary/Pancreatic
Parkinson’s disease
Business Unit
Responsibility
Corporate Profile
